Literature DB >> 28139065

Chiral separation of novel diazenes on a polysaccharide-based stationary phase in the reversed-phase mode.

Terézia Vojtylová1,2, Věra Hamplová1, Zbigniew Galewski3, Izabela Korbecka3, David Sýkora2.   

Abstract

Chiral high-performance liquid chromatography separation of two recently synthesized liquid crystalline materials C1 and C2 was studied in the reversed-phase mode. Both materials have an azo-moiety and one chiral center in their molecular structures. They were available in racemic and pure S forms. For the enantiomeric separations, a Chiralpak AY-RH stationary phase based on amylose tris(5-chloro-2-methylphenylcarbamate) coated on 5 μm silica was used. The compounds were analyzed in both of their possible forms, the more thermodynamically stable E form and the labile Z form. The conditions and time scale of the UV-induced E to Z transition were briefly evaluated. Under the optimized conditions, we were able to baseline separate S and R enantiomers of both of the studied materials not only in their E forms, but also in their Z forms. In comparison to the separation in the normal-phase mode, which we have reported recently, the resolution in the reversed-phase mode is significantly better. Interestingly, peak reversal was noticed for the S and R enantiomers when the separation was carried out with E versus Z forms of both compounds.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  azobenzene; chiral separation; high-performance liquid chromatography; liquid-crystalline materials; photo-induced isomerization

Year:  2017        PMID: 28139065     DOI: 10.1002/jssc.201601386

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Enantioselective HPLC Analysis to Assist the Chemical Exploration of Chiral Imidazolines.

Authors:  Bruno Cerra; Antonio Macchiarulo; Andrea Carotti; Emidio Camaioni; Ina Varfaj; Roccaldo Sardella; Antimo Gioiello
Journal:  Molecules       Date:  2020-02-02       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.